O. Randazzo

Most-cited papers

1. DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents

   M. V. Raimondi, O. Randazzo, M. La Franca, G. Barone +3 more

   2019Molecules200 citations Open access

   Semantic Scholar

   Save

2. “Open Sesame?”: Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic Cancer

   O. Randazzo, F. Papini, G. Mantini, A. Gregori +8 more

   2020Cancers32 citations Open access

   Semantic Scholar

   Save

3. New Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives Inhibit FAK Phosphorylation and Potentiate the Antiproliferative Effects of Gemcitabine Through Modulation of the Human Equilibrative Nucleoside Transporter-1 in Peritoneal Mesothelioma

   Giovanna Li Petri, C. Pecoraro, O. Randazzo, S. Zoppi +10 more

   2020Anticancer Research31 citations Open access

   Semantic Scholar

   Save

4. Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma

   I. Supadmanaba, G. Mantini, O. Randazzo, M. Capula +5 more

   2021Epigenetics9 citations Open access

   Semantic Scholar

   Save

5. SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance

   O. Randazzo, S. Cascioferro, C. Pecoraro, Widad Ait Iddouch +7 more

   2021Cancer Drug Resistance4 citations Open access

   Semantic Scholar

   Save

6. Updates on the biomarker status of the human equilibrative nucleoside transporter-1 and molecular mechanisms influencing its expression and activity in the uptake and cytotoxicity

   G. Mantini, F. Papini, M. Capula, O. Randazzo +6 more

   2021Pancreatology (Print)0 citations

   Semantic Scholar

   Save